Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

Miraculins to Distribute Device in China through Cachet Pharma

publication date: Aug 14, 2014
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
Miraculins, a Canadian diagnostics company, finalized an agreement for China distribution of its Scout DS® Non-Invasive Diabetes Screening Device. The device will be imported by Catalyn Medical Technologies Limited, a privately-owned Hong Kong company, and distributed by Cachet Pharma (SHE: 002462) of China. Cachet agreed to buy $90 million of the device over the five-year life of the contract. Miraculins will be responsible for obtaining CFDA approval of the device. More details....

Stock Symbol: (TVE: MOM)

Share this with colleagues:  


This article is available for purchase - please click here for details.


Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...

Login

  

    
   
Our Partners
Annual Sponsors
Official Partners
Supporting Partners
Media Sponsors